Founded Year
2019Stage
IPO | IPODate of IPO
1/12/2021About Qilian International
Qilian International (NASDAQ: QLI) is a pharmaceutical and chemical company based in China that focuses on the development, manufacturing, marketing, and sale of oxytetracycline products, licorice products, traditional Chinese medicine derivatives (“TCMD”) product, heparin product, sausage casings, and fertilizers.
Missing: Qilian International's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Qilian International's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest Qilian International News
Apr 27, 2023
China-based pharmaceutical and chemical products manufacturer, Qilian International (NASDAQ: QLI ) regains Nasdaq compliance after having failed to timely file its annual report for the year ended September 30, 2022. On April 20, 2023, the company received a second letter from Nasdaq stating that based on the April 19, 2023 filing, the company complies with the rules. Nasdaq now considers this matter closed. Recommended For You
Qilian International Frequently Asked Questions (FAQ)
When was Qilian International founded?
Qilian International was founded in 2019.
Where is Qilian International's headquarters?
Qilian International's headquarters is located at Jiuquan Economic and Technological Development Zone, Jiuquan.
What is Qilian International's latest funding round?
Qilian International's latest funding round is IPO.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.